tirzepatide microdosing study on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial Tirzepatide Microdosing: The Growing Off-Label

This drug requires close medical supervision

Whilst gastrointestinal side effects are well-recognised, some patients report itching or skin reactions during treatment

If you want or need something beyond compounded injectable semaglutide or tirzepatide, you will need to look elsewhere

New England Journal of Medicine, 392 (21), 20892099

The primary pharmacokinetic difference between the routes is therefore kinetic rather than total exposure: IM produces sharper, faster peaks while SubQ produces slower, more sustained plasma profiles

Then, you can optimize brain function, protect against neurological decline, and ensure a healthy brain